These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 21252069)
1. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice. Thatcher SE; Zhang X; Howatt DA; Lu H; Gurley SB; Daugherty A; Cassis LA Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):758-65. PubMed ID: 21252069 [TBL] [Abstract][Full Text] [Related]
2. Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis. Chen X; Lu H; Zhao M; Tashiro K; Cassis LA; Daugherty A Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2075-80. PubMed ID: 23846498 [TBL] [Abstract][Full Text] [Related]
3. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation. Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Gupte M; Thatcher SE; Boustany-Kari CM; Shoemaker R; Yiannikouris F; Zhang X; Karounos M; Cassis LA Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1392-9. PubMed ID: 22460555 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Lovren F; Pan Y; Quan A; Teoh H; Wang G; Shukla PC; Levitt KS; Oudit GY; Al-Omran M; Stewart DJ; Slutsky AS; Peterson MD; Backx PH; Penninger JM; Verma S Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1377-84. PubMed ID: 18660448 [TBL] [Abstract][Full Text] [Related]
7. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375 [TBL] [Abstract][Full Text] [Related]
8. Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice. Howatt DA; Balakrishnan A; Moorleghen JJ; Muniappan L; Rateri DL; Uchida HA; Takano J; Saido TC; Chishti AH; Baud L; Subramanian V Arterioscler Thromb Vasc Biol; 2016 May; 36(5):835-45. PubMed ID: 26966280 [TBL] [Abstract][Full Text] [Related]
9. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Thomas MC; Pickering RJ; Tsorotes D; Koitka A; Sheehy K; Bernardi S; Toffoli B; Nguyen-Huu TP; Head GA; Fu Y; Chin-Dusting J; Cooper ME; Tikellis C Circ Res; 2010 Oct; 107(7):888-97. PubMed ID: 20671240 [TBL] [Abstract][Full Text] [Related]
10. ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response. Zhang YH; Zhang YH; Dong XF; Hao QQ; Zhou XM; Yu QT; Li SY; Chen X; Tengbeh AF; Dong B; Zhang Y Inflamm Res; 2015 Apr; 64(3-4):253-60. PubMed ID: 25721616 [TBL] [Abstract][Full Text] [Related]
11. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells. Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229 [TBL] [Abstract][Full Text] [Related]
12. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling. Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758 [TBL] [Abstract][Full Text] [Related]
13. Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms. Wang S; Subramanian V; Lu H; Howatt DA; Moorleghen JJ; Charnigo R; Cassis LA; Daugherty A Atherosclerosis; 2012 Feb; 220(2):375-80. PubMed ID: 22153700 [TBL] [Abstract][Full Text] [Related]
14. Comparison of angiotensin-(1-7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice. Yang J; Sun Y; Dong M; Yang X; Meng X; Niu R; Guan J; Zhang Y; Zhang C Atherosclerosis; 2015 Jun; 240(2):544-9. PubMed ID: 25957120 [TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648 [TBL] [Abstract][Full Text] [Related]
16. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Zhang D; Fang P; Jiang X; Nelson J; Moore JK; Kruger WD; Berretta RM; Houser SR; Yang X; Wang H Circ Res; 2012 Jun; 111(1):37-49. PubMed ID: 22628578 [TBL] [Abstract][Full Text] [Related]
17. Regulation of ACE2 in cardiac myocytes and fibroblasts. Gallagher PE; Ferrario CM; Tallant EA Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2373-9. PubMed ID: 18849338 [TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice. Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831 [TBL] [Abstract][Full Text] [Related]
20. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade. Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]